Lifevantage Revenue, Net Income & 10-K Summary

Company overview

LifeVantage is a nutrigenomics-focused direct selling company that develops, contracts out manufacture, markets, and sells products intended to support health and wellness. The product portfolio emphasizes activation of cellular pathways through nutrigenomic ingredients and is distributed via independent consultants under a direct-sales model.
Core product families:
- Protandim® line (Nrf2 Synergizer, NAD Synergizer, NRF1 Synergizer)
- LifeVantage® line (MindBody GLP-1 System, Omega+, ProBio, IC Bright®, Rise AM & Reset PM System, D3+, Daily Wellness, Fat Burn, Prebiotic, Carb Block)
- TrueScience® line (skin and hair care, including TrueScience® Liquid Collagen)
- P84 System (gut health activator; PhytoPower 1 & 2)
- Petandim® (dog supplement)
- AXIO® line (nootropic and energy/hydration drink mixes; AXIO Smart Energy, AXIO X, AXIO Hydrate)
Stacks and bundles: Product stacks combine related products to enhance activation effects (for example, the Healthy Edge stack combining Protandim Nrf2 Synergizer and the P84 System).

Markets: United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, United Kingdom, Netherlands, Germany, Austria, Spain, Ireland, Belgium, Iceland, Portugal. Hong Kong and Singapore ceased operations on May 31, 2026.
Revenue geography (fiscal year 2026):
- Americas: 78.2% (approximately $142.7 million)
- Asia/Pacific & Europe: 21.8% (approximately $39.9 million)
Revenue:
- Total revenue FY2026: $182.6 million
- Total revenue FY2025: $228.5 million
Customers and consultants:
- Active customers: ~61,000 (June 30, 2026); ~81,000 (June 30, 2025)
- Independent consultants (active): ~43,000 (June 30, 2026); ~51,000 (June 30, 2025)
Corporate offices and facilities:
- Headquarters: Lehi, Utah (3300 N. Triumph Blvd., Suite 700)
- Japan office lease in Tokyo renewed through June 30, 2028 (5,200 sq ft)
- Global sourcing and fulfillment conducted through third-party contract manufacturers and logistics partners

Direct selling model: Independent consultants enroll as independent contractors, purchase products for resale or personal use, and earn commissions on sales to personally enrolled customers and on sales within their downline.
Evolve Compensation Plan: Implemented starting in 2023 in the U.S., Australia, New Zealand, and Japan, and expanded to additional markets through 2025. The plan provides daily, weekly, and monthly payments, with incentives tied to product sales and customer subscription growth; optimizations continued in 2025 and 2026.
Rewards and engagement: Training and events (Momentum Academy, Global Convention), promotions and incentives, a mobile app for consultant support, the Global Not For Resale program for cross-border customer purchases, and consultant compliance monitoring.

Focus: Products designed to activate cellular pathways (Nrf2, NRF1, NAD, GLP-1 system) and support gut, metabolic, immune, skin, eye, and cognitive health.
Product highlights:
- Protandim Nrf2 Synergizer, Protandim NRF1 Synergizer, Protandim NAD Synergizer
- MindBody GLP-1 System (MB Core, MB Enhance) for weight and metabolic support
- Omega+ (DHA/EPA, omega-7, vitamin D3)
- ProBio, IC Bright, Daily Wellness, Rise AM & Reset PM, D3+, Fat Burn, Prebiotic, Carb Block
- P84 System (PhytoPower 1 & 2), acquired from LoveBiome
- TrueScience® line (TrueLiquid Collagen, Glow-related stack)
- Petandim® (NASC Quality Seal)
- AXIO® (Smart Energy, X, Hydrate)
Intellectual property:
- Patents on the Tri-Synergizer combination (Protandim) and a patent for the Healthy Glow stack (Protandim Nrf2 Synergizer + TrueScience Liquid Collagen) issued in 2026
- Patent applications filed for the MindBody GLP-1 System (U.S. filing in 2025) and for the P84 System (filed in 2026)
- Trademarks for Protandim, LifeVantage, TrueScience, MB System, MB Core, MB Enhance, and related marks

Manufacturing, fulfillment, and shipping are outsourced to multiple contract manufacturers.
Relies on third-party suppliers for raw materials and maintains alternative suppliers; operates a Vendor Code of Conduct aligned with UN Global Compact principles.
Past voluntary recall related to a turmeric extract in Protandim Nrf2 Synergizer; ongoing quality controls and safety measures are in place.

The company protects its brands through patents and trademarks and uses trade secret protections and confidentiality agreements to safeguard proprietary know-how.

Products are marketed as dietary supplements or foods in many markets and are subject to U.S. FDA/FTC oversight under DSHEA and comparable foreign regulatory regimes.
Direct selling activities are subject to U.S. DSA and DSSRC oversight; the company maintains monitoring and compliance programs.
Primary regulatory risks include advertising claims, claims substantiation, and potential regulatory actions or recalls.

Employees: 223 total (as of June 30, 2026)
- Full-time: 209
- Based in the U.S.: 169
- Based internationally: 54
Independent consultants are independent contractors and not employees.

Revenue:
- FY2026: $182.6 million
- FY2025: $228.5 million
Regional revenue mix (FY2026):
- Americas: 78.2%
- Asia/Pacific & Europe: 21.8%
Cash and financing:
- 2024 Credit Facility: revolving line of credit up to $5.0 million (amended Sept 2025)
- As of June 30, 2026: no outstanding balance on the facility
- Facility maturity: April 12, 2027
- The facility is secured by a lien on substantially all assets of LifeVantage and Lifeline Nutraceuticals and includes covenants and financial tests
Other financial considerations: inventory and supply risks, foreign currency exposure tied to U.S. and Japan revenues, and potential impact from tariffs and trade policies
Shareholder considerations:
- Delaware corporation with a stock repurchase program (up to $60 million through Dec 31, 2027)
- As of June 30, 2026: 12.5 million shares outstanding; outstanding options and RSUs may dilute share count
- Potential governance and market risks include stock price volatility and activist investor activity

Headquarters: Lehi, Utah
Global footprint includes a Japan office with lease arrangements and targeted expansion
Distribution occurs via direct-to-consumer channels and the independent consultant network; fulfillment centers process orders daily

Acquired LoveBiome’s critical operating assets in October 2025
U.S. product launches: P84 System, PhytoPower B (rebranded to LifeVantage Carb Block), AXIO X, AXIO Hydrate
Launched the Healthy Edge stack (Protandim Nrf2 Synergizer + P84 System)
Introduced limited-edition AXIO Smart Energy flavors in the U.S. and Japan
Petandim launched in Mexico; TrueScience Glow-Up Mask offered as a limited-time product
Expanded MB System offerings in Europe and added limited product availability in Iceland and Portugal
Continued investments in eCommerce, consultant tools, data integration, and AI-enabled capabilities